Browse studies

Find your next paid study

77 recruiting studies matching your filters

A Two-Part Phase 1, Randomized, Double-Blind, Placebo-Controlled First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN20423 in Adult Healthy Participants and Adult Participants With Atopic Dermatitis

This study will test a study medicine called REGN20423 to see how effective it is in healthy participants (in Part A) and participants with atopic dermatitis (…

Healthy VolunteerAtopic Dermatitis

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT07527923

Phase 1

A Randomized, Blinded, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 in HVs and Adult Patients With AD

This is a Phase 1, randomized, blinded, placebo controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study of BBT001 in healthy volunteers…

Atopic Dermatitis

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Bambusa TherapeuticsNCT06808477

Phase 4

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

The goal of this clinical trial is to demonstrate the feasibility of a trial that examines the impact of changes in dietary sodium intake on skin sodium levels…

Atopic Dermatitis (Eczema)Psoriasis

Estimated

~$25 – $900

Actual pay is set by the research site.

University of California, San FranciscoNCT07487831

A Prospective, Multi-center Observational Study Characterizing Clinical Outcomes of Patients Receiving Abrocitinib for Moderate-to-severe Atopic Dermatitis Who Had an Inadequate Response (or Intolerance) to ≤2 Previous Biologic Therapies Approved for Moderate-to-severe Atopic Dermatitis

This is a prospective, multi-center observational study characterizing clinical and patient reported outcomes of patients receiving abrocitinib for moderate-to…

Atopic DermatitisAtopic Dermatitis, UnspecifiedDermatitis, Atopic

Estimated

~$10 – $1,125

Actual pay is set by the research site.

PfizerNCT06899204

A US-Prospective, Registry-Based, Observational, Exposure Cohort Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

This observational (enrollment into the registry while the pregnancy is ongoing) study is being conducted to compare the frequency of major congenital malforma…

Pregnancy RelatedAtopic Dermatitis

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Incyte CorporationNCT06259669

Longitudinal "Real-World" Changes in Skin Microbial Ecology in Atopic Dermatitis (AD) and Psoriasis (PS) Patients

Everybody's skin has bacteria that normally lives on it. Previous research has shown that people with eczema (or atopic dermatitis \[AD\]) have much higher con…

Atopic DermatitisPsoriasisHealthy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of RochesterNCT04170244

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

This protocol is primarily looking to see if the IL-4Ra R576 polymorphism is associated with increased clinical, immunological and microbial markers of disease…

Atopic Dermatitis

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT04455906

Registry for Systemic Eczema Treatments

The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) w…

Atopic Dermatitis

Estimated

~$10 – $750

Actual pay is set by the research site.

Johns Hopkins UniversityNCT06136767

Phase 4

The Impact of Dietary Salt on the Severity of Eczema

The goal of this clinical trial is to evaluate the feasibility of low-sodium diet to improve eczema severity. The main questions it aims to answer are: * Does…

EczemaAtopic Dermatitis

Estimated

~$25 – $900

Actual pay is set by the research site.

University of California, San FranciscoNCT07447063

Phase 2

Use of Specific JAK Inhibition on Inflammatory Skin and Scalp Diseases in Down Syndrome R61AR084210

This is a single-center, open-label, basket phase 2b trial that will enroll Down Syndrome (DS) participants with at least one inflammatory skin condition (Atop…

Atopic DermatitisAlopecia Areata

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Icahn School of Medicine at Mount SinaiNCT07242638

Phase 1

Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis

This study aims to assess the efficacy of upadacitinib in eyelid dermatitis that has not resolved with topical therapies and patch testing.

Eyelid Dermatitis

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Northwestern UniversityNCT06684522

Phase 2

A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08049820 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as ecze…

Atopic DermatitisEczema, Atopic

Estimated

~$75 – $3,000

Actual pay is set by the research site.

PfizerNCT07216027